# Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants

> **NCT03210909** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 5 (actual)

## Conditions studied

- Heart Decompensation, Acute

## Interventions

- **DRUG:** BMS-986231

## Key facts

- **NCT ID:** NCT03210909
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-22
- **Primary completion:** 2017-07-20
- **Final completion:** 2017-07-20
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03210909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03210909, "Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03210909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*